| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/09/2001 | WO2001057057A1 Mammalian sphingosine-1-phosphate phosphatase |
| 08/09/2001 | WO2001056604A1 Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies |
| 08/09/2001 | WO2001056603A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | WO2001056600A1 Method of controlling the qualities of attenuated pox vaccine |
| 08/09/2001 | WO2001056596A1 Use of lysosomal acid lipase for treating atherosclerosis and related diseases |
| 08/09/2001 | WO2001056376A1 Transgenic non-human animal overexpressing gli-1, as a cancer model system |
| 08/09/2001 | WO2001056375A1 Tob gene-defective knockout nonhuman mammal |
| 08/09/2001 | WO2001056355A2 Human immunodeficiency virus vaccine |
| 08/09/2001 | WO2001027248A8 Prpp-amidotransferase from nicotiana tabacum |
| 08/09/2001 | WO2001021819A3 Method for genetic modification of lactobacillus delbrueckii |
| 08/09/2001 | WO2001021796A3 Gl50 molecules and uses therefor |
| 08/09/2001 | WO2001020008A3 Vascular-specific promoters |
| 08/09/2001 | WO2001019989A3 Method of producing and purifying endostatintm protein |
| 08/09/2001 | WO2001019966A3 Isolation of muscle-derived stem cells and uses therefor |
| 08/09/2001 | WO2001016312A3 Nucleic acid based modulators of gene expression |
| 08/09/2001 | WO2001007647A3 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 08/09/2001 | WO2001007641A3 Method for expressing a library of nucleic acid sequence variants and selecting desired traits |
| 08/09/2001 | WO2001007639A3 Selectable marker gene |
| 08/09/2001 | WO2001007622A3 DNA SEQUENCES THAT ENCODE TYPE II (xcp) SECRETION SYSTEMS |
| 08/09/2001 | WO2001007587A3 Dna sequences coding for iron and heavy metal transporters |
| 08/09/2001 | WO2001007574A3 Modified cytochrome p450 monooxygenases |
| 08/09/2001 | WO2001007568A3 Muscle cells and their use in cardiac repair |
| 08/09/2001 | WO2001007451A3 Isolation of biomolecules |
| 08/09/2001 | WO2001007066A3 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 08/09/2001 | WO2001006988A3 Super-active porcine growth hormone releasing hormone analog |
| 08/09/2001 | WO2001006004A3 A method for amplifying low abundance nucleic acid sequences and means for performing said method |
| 08/09/2001 | WO2001005951A3 Novel sgs3 plant gene and use thereof |
| 08/09/2001 | WO2001005945A3 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/09/2001 | WO2001005940A3 Methods for producing and preparing cells for cell therapy |
| 08/09/2001 | WO2001004351A3 Genetic test for detecting a predisposition to a disease associated with abnormal vegf gene expression |
| 08/09/2001 | WO2001004318A3 Myxoma virus genes for immune modulation |
| 08/09/2001 | WO2001004316A3 Antigenic meningococcal peptides |
| 08/09/2001 | WO2001002590A3 Plants with modified gene expression |
| 08/09/2001 | WO2001002589A3 Methods, compositions and genetic sequences for modulating flowering in plants, and plants genetically modified to flower early and tardily |
| 08/09/2001 | WO2000078361A3 Methods of imaging and targeting tumor vasculature |
| 08/09/2001 | WO2000077216A3 Porcine circovirus vaccine in recombinant poxvirus |
| 08/09/2001 | WO2000077187A3 Promoter system and production and use of the same |
| 08/09/2001 | WO2000074646A3 Novel liposomal vector complexes and their use in gene therapy |
| 08/09/2001 | WO2000073499A3 Nucleic acid probes and methods for detecting clinically important fungal pathogens |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070097A3 Profile searching in nucleic acid sequences using the fast fourier transformation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | WO2000069895A3 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 08/09/2001 | WO2000069257A3 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 08/09/2001 | WO2000068421A3 Method for detecting microorganisms in a sample |
| 08/09/2001 | WO2000066716A3 Method for producing organisms exhibiting increased sterol glycoside production and use of the sterol glycosides |
| 08/09/2001 | WO2000064941A3 G-protein coupled receptor and method of using same |
| 08/09/2001 | WO2000063351A3 Carbohydrate-modifying enzymes |
| 08/09/2001 | WO2000061729A3 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules |
| 08/09/2001 | WO2000060103A3 Dna construct comprising a cyanophage of cyanobacteria promoter and its use |
| 08/09/2001 | WO2000058510A3 Schizophrenia associated genes, proteins and biallelic markers |
| 08/09/2001 | WO2000056929A3 Coupled polymerase chain reaction-restriction endonuclease digestion-ligase detection reaction process |
| 08/09/2001 | WO2000049035A9 Gene silencing |
| 08/09/2001 | WO2000037643A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/09/2001 | WO2000006713A3 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 08/09/2001 | US20010013135 Methods for controlling cell death in plants |
| 08/09/2001 | US20010013134 Transgenic mammal; polynucleotide containing pancreas promoter |
| 08/09/2001 | US20010012983 Methods for determining therapeutic index from gene expression profiles |
| 08/09/2001 | US20010012890 Administering caveolin antibody nucleic acid |
| 08/09/2001 | US20010012889 36 human secreted proteins |
| 08/09/2001 | US20010012888 Compounds for diagnosis of tuberculosis and methods of their use |
| 08/09/2001 | US20010012887 Cloning and uses of the genetic locus bcl-6 |
| 08/09/2001 | US20010012886 Polypeptide compositions for controlling cell death and disease resistance in plants |
| 08/09/2001 | US20010012836 Determining the presence or absence of a mutation in the nucleotide sequence or absence of a mutation in nucleotide sequence encoding the specific polypeptides in the genome of the subject and analyzing for presence of polypeptide |
| 08/09/2001 | US20010012831 Calcium-binding protein |
| 08/09/2001 | US20010012632 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response |
| 08/09/2001 | US20010012630 Yeast in which acetyl CoA-pregnenolone acetyltransferase (APAT) activity is elimiated by altering the gene coding for this activity, ATF2; this prevents 3beta-acetate ester of the steroid byproduct and stabilizes 3beta-hydroxysteroids |
| 08/09/2001 | US20010012627 Neurotransmitter transporter SC6 |
| 08/09/2001 | US20010012626 Polynucleotides encoding Presenilin 1 (PS1); diagnosing a patient having an increased likelihood of contracting Alzheimer's disease |
| 08/09/2001 | US20010012625 Ngf variants |
| 08/09/2001 | US20010012621 Determining the expression of lysyl oxidase, the expression of lysyl oxidase indicating that the compound is capable of suppressing ras functions |
| 08/09/2001 | US20010012618 Useful for enzymatic cleavage of RNA or single stranded DNA, and also as antisense oligonucleotides; improved stability and activity |
| 08/09/2001 | US20010012617 For preparing cDNA from a mRNA using a reverse transcriptase where the reverse transcription is performed at a temperature at which mRNA do not take a secondary structure; improved heat stability of RNA by including metal ion chelator |
| 08/09/2001 | US20010012616 Probe including a crosslinking agent hybridized with target sequence, then conditions are change to allow crosslinking and sample is separated by gel electrophoresis where mismatches have different migratory rate; kits |
| 08/09/2001 | US20010012516 Viral vectors |
| 08/09/2001 | US20010012515 Isolated polypeptide |
| 08/09/2001 | US20010012513 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 08/09/2001 | EP1144611A3 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 08/09/2001 | DE10024132A1 Anordnung zur Detektion von Fluoreszenzlicht mehrer Probenpunkte Arrangement for detecting fluorescent light several sample points |
| 08/09/2001 | DE10003653A1 Vektorkonstrukte zur gentherapeutisch vermittelten Radioiodtherapie entdifferenzierter und medullärer Schilddrüsen-Karzinome sowie nicht-thyreoidaler Tumore und ihrer Metastasen Vector constructs for gene therapy mediated radioiodine therapy of medullary thyroid carcinoma and dedifferentiated and non-thyroidal tumors and their metastases |
| 08/09/2001 | DE10003573A1 Hemmung von Kohlenhydrat-modifizierenden Enzymen in Wirtsorganismen Inhibition of carbohydrate-modifying enzymes in host organisms |
| 08/09/2001 | DE10001834A1 Method of determining geographical location of mobile unit using single communication satellite by calculating two possible location regions of mobile unit based on intersection of first and second instantaneous distances |
| 08/09/2001 | CA2400013A1 Methods of protein destabilization and uses thereof |
| 08/09/2001 | CA2400006A1 Signaling aptamers that transduce molecular recognition to a differential signal |
| 08/09/2001 | CA2399982A1 G-protein coupled receptors |
| 08/09/2001 | CA2399809A1 Combinatorial protein domains |
| 08/09/2001 | CA2399727A1 Narc-1, subtilase-like homologs |
| 08/09/2001 | CA2399686A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | CA2399683A1 Mammalian sphingosine-1-phosphate phosphatase |
| 08/09/2001 | CA2399672A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399663A1 Novel human enzymes and polynucleotides encoding the same |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399644A1 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399633A1 Novel human membrane proteins and polynucleotides encoding the same |
| 08/09/2001 | CA2399561A1 Ruminant mhc class i-like fc receptors |
| 08/09/2001 | CA2399333A1 Method for identifying and/or characterizing a (poly)peptide |
| 08/09/2001 | CA2399267A1 Protein c derivatives |
| 08/09/2001 | CA2399149A1 Plant adpglucose pyrophosphatase, process for the production, use in themanufacture of assay devices and in producing transgenic plants |
| 08/09/2001 | CA2399080A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | CA2399058A1 Targeting peptides |